Our results showed that mutated p53 mediated the induction of transcription of NF-κB regulated genes by doxorubicin and functional restoration of wild-type p53 impaired doxorubicin- NF-κB dependent transcription in breast cancer. The gene discussed is TP53; the disease is breast carcinoma.